Back to Search Start Over

Cost-effectiveness of gastric band surgery for overweight but not obese adults with type 2 diabetes in the U.S

Authors :
Paul E. O'Brien
Wendy A. Brown
Philip Clarke
Kim Dalziel
Neda Laiteerapong
John M. Wentworth
Paul Burton
Frackson Shaba
Publication Year :
2017

Abstract

To determine the cost-effectiveness of gastric band surgery in overweight but not obese people who receive standard diabetes care.A microsimulation model (United Kingdom Prospective Diabetes Study outcomes model) was used to project diabetes outcomes and costs from a two-year Australian randomized trial of gastric band (GB) surgery in overweight but not obese people (BMI 25 to 30kg/mThe incremental cost-effectiveness ratio for GB surgery at two years exceeded $90,000 per quality-adjusted life year gained but decreased to $52,000, $29,000 and $22,000 when the health benefits of surgery were assumed to endure for 5, 10 and 15 years respectively. The cost-effectiveness of GB surgery was sensitive to utility gained from weight loss and, to a lesser degree, the costs of GB surgery. However, the cost-effectiveness of GB surgery was affected minimally by improvements in HbA1c, systolic blood pressure and cholesterol.GB surgery for overweight but not obese people with T2D appears to be cost-effective in the U.S. setting if weight loss endures for more than five years. Health utility gained from weight loss is a critical input to cost-effectiveness estimates and therefore should be routinely measured in populations undergoing bariatric surgery.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....e2f2f01d6516b38b3a5f96503e1bdd0d